Operating Lease, Right-of-Use Asset of bioAffinity Technologies, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
bioAffinity Technologies, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • bioAffinity Technologies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $367,398, a 26% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

bioAffinity Technologies, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $367,398 -$126,289 -26% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $399,879 +$74,937 +23% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $431,746 +$83,886 +24% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $463,011 +$92,699 +25% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $493,687 +$101,340 +26% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $324,942 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $347,860 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $370,312 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $392,347 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.